Primary Site >> Biliary tract Cancer

Gene >> KLRK1

Journal: Hepatology. 2008 Jan;47(1):90-6.
Title: Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Author: Melum, Espen|Karlsen, Tom H|Schrumpf, Erik|Bergquist, Annika|Thorsby, Erik|Boberg, Kirsten M|Lie, Benedicte A
PMID: 18023027
Journal: Int J Cancer. 2008 Jul 1;123(1):241-2.
Title: Investigation of cholangiocarcinoma associated NKG2D polymorphisms in colorectal carcinoma.
Author: Melum, Espen|Buch, Stephan|Schafmayer, Clemens|Kalthoff, Holger|Tepel, Jurgen|Schreiber, Stefan|Karlsen, Tom H|Hampe, Jochen
PMID: 18398827
Journal: Anticancer Res. 2012 Jun;32(6):2249-56.
Title: Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
Author: Morisaki, Takashi|Umebayashi, Masayo|Kiyota, Akifumi|Koya, Norihiro|Tanaka, Hiroto|Onishi, Hideya|Katano, Mitsuo
PMID: 22641659
Journal: Cancer Sci. 2016 Feb;107(2):116-22.
Title: Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.
Author: Tsukagoshi, Mariko|Wada, Satoshi|Yokobori, Takehiko|Altan, Bolag|Ishii, Norihiro|Watanabe, Akira|Kubo, Norio|Saito, Fumiyoshi|Araki, Kenichiro|Suzuki, Hideki|Hosouchi, Yasuo|Kuwano, Hiroyuki
PMID: 26608587
Journal: J Cancer. 2017 Jan 1;8(1):74-84.
Title: Activation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysis.
Author: Wang, Ying|Ding, Min|Zhang, Qian|Wang, Jinghan|Yang, Xijing|Zhou, Fuping|Li, Linfang|Yuan, Zhengang|Jin, Huajun|Qian, Qijun
PMID: 28123600